Banque Cantonale Vaudoise’s Jazz Pharmaceuticals JAZZ Stock Holding History

Banque Cantonale Vaudoise’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-842	Closed	-$109K	–	1122
2023 Q3	$109K	Sell	842 -863	-51%	-$115K	0.01%	812
2023 Q2	$211K	Hold	1,705	–	–	0.01%	706
2023 Q1	$250K	Hold	1,705	–	–	0.01%	644
2022 Q4	$272K	Hold	1,705	–	–	0.01%	627
2022 Q3	$227K	Hold	1,705	–	–	0.01%	688
2022 Q2	$266K	Buy	1,705 +352	+26%	+$54.2K	0.01%	664
2022 Q1	$211K	Sell	1,353 -300	-18%	-$43.5K	0.01%	786
2021 Q4	$210K	Hold	1,653	–	–	0.01%	819
2021 Q3	$215K	Buy	1,653 +445	+37%	+$67.2K	0.01%	784
2021 Q2	$214K	Buy	1,208 +203	+20%	+$35.2K	0.01%	826
2021 Q1	$165K	Sell	1,005 -144	-13%	-$23.7K	0.01%	812
2020 Q4	$190K	Hold	1,149	–	–	0.01%	738
2020 Q3	$165K	Sell	1,149 -4,000	-78%	-$496K	0.01%	732
2020 Q2	$568K	Hold	5,149	–	–	0.04%	359
2020 Q1	$514K	Sell	5,149 -6,200	-55%	-$802K	0.04%	360
2019 Q4	$1.69M	Buy	+11,349	New	+$1.54M	0.12%	201

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Banque Cantonale Vaudoise's JAZZ Position: Q4 2023 in Review

Banque Cantonale Vaudoise sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2023, closing a stake of 842 shares — an estimated $109K sold.

Banque Cantonale Vaudoise first reported a position in JAZZ in Q4 2019 and held it in 16 quarters. The position peaked at $1.69M in Q4 2019. 500 funds tracked by Wall St. Rank hold JAZZ as of Q4 2023.

Banque Cantonale Vaudoise reported no remaining Jazz Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Banque Cantonale Vaudoise sold 842 Jazz Pharmaceuticals shares in Q4 2023, an estimated $109K.
Banque Cantonale Vaudoise first reported a position in Jazz Pharmaceuticals in Q4 2019 and held it in 16 quarters.
Banque Cantonale Vaudoise's Jazz Pharmaceuticals position peaked at $1.69M in Q4 2019.
500 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2023.

Based on Banque Cantonale Vaudoise's 13F filing for Q4 2023, filed 7 Feb 2024.